Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,780 | -30,130 | -26,900 | -1,030 | 4,520 |
| Depreciation Amortization | 8,280 | 6,000 | 4,320 | 2,380 | 8,440 |
| Other Working Capital | 10,160 | 22,880 | 19,580 | -6,150 | -7,520 |
| Other Operating Activity | 26,090 | 9,010 | 9,000 | 0 | 480 |
| Operating Cash Flow | $6,750 | $7,760 | $6,000 | $-4,800 | $5,920 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,080 | -5,520 | -4,370 | -2,730 | -9,920 |
| Other Investing Activity | -5,800 | -6,160 | -4,590 | 460 | 13,030 |
| Investing Cash Flow | $-12,880 | $-11,680 | $-8,960 | $-2,270 | $3,110 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -240 | -750 | -590 | -930 | -1,120 |
| Financing Cash Flow | $-240 | $-750 | $-590 | $-930 | $-1,120 |
| Beginning Cash Position | 15,550 | 15,550 | 15,550 | 15,550 | 7,640 |
| End Cash Position | 9,180 | 10,880 | 12,000 | 7,530 | 15,550 |
| Net Cash Flow | $-6,360 | $-4,670 | $-3,550 | $-8,010 | $7,910 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,750 | 7,760 | 6,000 | -4,800 | 5,920 |
| Free Cash Flow | 6,750 | 7,760 | 6,000 | -4,800 | 5,920 |